Skip to main content
Equibles
ALKS logo

ALKS · Alkermes plc.

Track ALKS — free

Use ALKS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$46.10 -0.78 (-1.66%) At close · Sep 4
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$7.80B
Shares
167.76M

ALKS metrics

71 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$46.10
Market cap
$7.80B

Price action

19 metrics
Price change (1W)
-2.8%
Price change (30D)
-4.7%
Price change (3M)
+7.7%
Price change (6M)
+61.0%
Price change (YTD)
+64.8%
Price change (1Y)
+59.4%
Trailing year
Price change (5Y)
+54.4%
52-week high
$55.22
52-week low
$26.52
Change from 52-week high
-16.5%
Change from 52-week low
+73.8%
Annualized volatility
41.0%
Beta
0.8
RSI (14D)
35.8
Price vs SMA 50
-8.8%
Price vs SMA 200
+22.2%
Avg volume (3M)
1.91M
Relative volume
0.6
Average dollar volume
$94.57M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
167.76M

Valuation

12 metrics
P / E (TTM)
121.3
Trailing earnings · reciprocal yield 0.8%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
4.7×
reciprocal yield 21.4%
P / book
4.3
reciprocal yield 23.2%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
31.0
reciprocal yield 3.2%
Earnings yield
0.8%

Historical valuation

8 metrics
P / E historical average (3Y)
27.1×
reciprocal yield 3.7%
P / E historical average (5Y)
29.1×
reciprocal yield 3.4%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-28

Profitability

9 metrics
Gross margin
84.6%
Operating margin
7.0%
Trailing 12 months
Net margin
4.0%
Gross profit (TTM)
—
Operating profit (TTM)
$117.26M
Net income (TTM)
$66.12M
Trailing 12 months
Diluted EPS (TTM)
$0.38
FCF margin
—
Effective tax rate
32.1%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+27.0%
Year over year
Net income growth YoY
-99.4%
Revenue (TTM)
$1.67B
Trailing 12 months
EPS growth YoY
-100.0%
Shares change YoY
+3.0%
Year over year · more shares
Revenue CAGR (3Y)
+9.9%
Revenue CAGR (5Y)
+7.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
+63.9%

Quality

14 metrics
Return on equity
3.7%
Return on assets
1.5%
Debt / equity
0.8
Current ratio
2.3
EBITDA (TTM)
$178.89M
Free cash flow (TTM)
—
Quick ratio
1.8
Interest coverage
2.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$511.53M
Total assets
$4.39B
Total debt
$1.50B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$251.18M
Capital expenditures (TTM)
—
R&D (TTM)
$391.04M
SG&A (TTM)
$841.19M
Stock compensation (TTM)
$118.41M
R&D / revenue
23.4%
Stock compensation / revenue
7.1%

Ownership (13F)

3 metrics
13F filers
425
13F filer change QoQ
+32
Institutional ownership
107.0%

Short interest

3 metrics
Short interest
8.8%
Latest settlement · 10.2 days to cover
Days to cover
10.2d
Short-squeeze score
72 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4.33M
Insider-sentiment score
35 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1520262 CUSIP G01767105 13F (30d) 303 filings 298 filers Visit website Investor relations